SREBF1 Gene

Introduction

Srebf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

| **SREBF1 Gene** | | |---|---| | **Full Name** | Sterol Regulatory Element Binding Transcription Factor 1 | | **Symbol** | SREBF1 (SREBP1) | | **Chromosome** | 17p11.2 | | **NCBI Gene ID** | 6720 | | **OMIM** | 184756 | | **Ensembl ID** | ENSG00000172318 | | **UniProt** | P36956 | | **Associated Diseases** | Alzheimer's Disease, Parkinson's Disease, Metabolic Syndrome, Fatty Liver Disease, Huntington's Disease, ALS |

Overview

The SREBF1 gene (commonly known as SREBP1) encodes sterol regulatory element-binding protein 1, a critical transcription factor that regulates lipid metabolism and cellular energy homeostasis^{1SREBPs: transcriptional activators of the complete program of cholesterol and fatty acid synthesis in the liver2002 · DOI 10.1172/JCI15593Open reference}. SREBP1 serves as the master regulator of fatty acid and triglyceride synthesis, controlling genes involved in lipogenesis, cholesterol biosynthesis, and lipid droplet formation. Beyond its well-established role in metabolic diseases, SREBP1 has emerged as an important player in neurodegenerative disorders, where lipid dysregulation contributes to disease pathogenesis^{2Retrospective on Cholesterol Homeostasis: The Central Role of SREBP2018 · DOI 10.1101/cshperspect.a033290Open reference}.

Protein Family and Isoforms

SREBP1 belongs to the SREBP family of transcription factors:

Isoform	Gene	Function	Tissue Expression
SREBP1a	SREBF1	Strong activator, full-length	Widely expressed
SREBP1c	SREBF1	Insulin-regulated isoform	Liver, adipose, brain

The SREBP1 gene produces multiple transcripts through alternative splicing:

• SREBP1a: More potent transcription factor, wider target gene range

• SREBP1c: Primarily regulates fatty acid synthesis, insulin-responsive

Protein Structure

SREBP1 contains several functional domains:

• N-terminal transcription activation domain - Transactivates target genes

• Sterol-sensing domain - Responds to sterol levels

• Basic-helix-loop-helix-leucine zipper (bHLH-LZ) - DNA binding

• C-terminal regulatory domain - Interactions with SCAP and INSIG

Molecular Function

Lipid Metabolism Regulation

SREBP1 controls the expression of genes involved in^{3SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology2017 · DOI 10.1038/nrendo.2017.91Open reference}:

Fatty Acid Synthesis:

• ACC (Acetyl-CoA carboxylase)

• FAS (Fatty acid synthase)

• SCD1 (Stearoyl-CoA desaturase)

Triglyceride Synthesis:

• GPAT (Glycerol-3-phosphate acyltransferase)

• DGAT (Diacylglycerol acyltransferase)

Cholesterol Synthesis:

• HMG-CoA reductase (rate-limiting)

• HMG-CoA synthase

• Squalene synthase

Cellular Processes

Beyond lipid synthesis, SREBP1 regulates:

1. ER stress response - Links lipid metabolism to unfolded protein response

2. Autophagy - Modulates lipid droplet catabolism

3. Inflammation - NF-κB signaling modulation

4. Cell growth - Coordinates lipid availability with proliferation

Regulation

Transcriptional Regulation

• Insulin signaling: PI3K/Akt pathway activates SREBP1c

• Glucose: ChREBP cooperation

• Leptin: Negative regulation

• Glucocorticoids: Activation

Post-translational Regulation

• Proteolytic cleavage: SCAP-mediated ER to Golgi trafficking

• Sterol feedback: Cholesterol levels control maturation

• Phosphorylation: mTOR and AMPK modify activity

• Ubiquitination: Protein stability control

Expression Pattern

Brain Regional Distribution

SREBP1 is expressed throughout the brain:

• Cerebral cortex - High neuronal expression

• Hippocampus - CA regions, dentate gyrus

• Cerebellum - Purkinje cells

• Hypothalamus - Metabolic regulation

• Substantia nigra - Dopaminergic neurons

• Striatum - Medium spiny neurons

Cell Type Specificity

• Neurons: Moderate expression, activity-dependent

• Astrocytes: High expression for lipid provision

• Oligodendrocytes: Myelin lipid synthesis

• Microglia: Modulated by inflammation

Disease Associations

Alzheimer’s Disease (AD)

SREBP1 dysregulation is prominent in AD^{4SREBP1 in Alzheimer's Disease: A Potential Therapeutic Target2022 · DOI 10.3389/fnagi.2022.856785Open reference}:

Lipid Metabolism Abnormalities:

• Altered brain cholesterol homeostasis

• Changed fatty acid composition

• Lipid droplet accumulation in glia

Amyloid Processing:

• SREBP1 affects APP processing

• Altered γ-secretase activity

• Aβ-induced lipotoxicity

Therapeutic Implications:

• SREBP1 modulators under investigation

• Diet interventions affect SREBP1

• Statins have indirect effects

Parkinson’s Disease (PD)

SREBP1 involvement in PD^{5Beyond the brain: widespread pathology in Huntington's disease2019 · DOI 10.1016/S1474-4422(19Open reference}:

• α-Synuclein interaction: Lipid environments affect aggregation

• Mitochondrial function: Lipid composition affects respiration

• Neuroinflammation: SREBP1 modulates glial activation

• Dopaminergic vulnerability: Lipid homeostasis critical

Huntington’s Disease (HD)

SREBP1 dysfunction in HD:

• Transcriptional dysregulation: Mutant huntingtin affects SREBP1

• Metabolic abnormalities: Lipid metabolism altered

• Therapeutic target: SREBP1 modulation may help

Amyotrophic Lateral Sclerosis (ALS)

• Lipid metabolism in motor neurons

• Energy homeostasis disruption

• Lipid droplet accumulation

Metabolic Syndrome

SREBP1 hyperactivity contributes to:

• Obesity: Increased lipogenesis

• Fatty liver: Hepatic lipid accumulation

• Insulin resistance: Lipid intermediates interfere with signaling

• Dyslipidemia: Elevated triglycerides

Therapeutic Implications

Pharmacological Approaches

Approach	Compound	Mechanism	Status
SREBP1 inhibitor	Fatostatin	Prevents cleavage	Preclinical
SREBP1 inhibitor	Betulin	Blocks maturation	Preclinical
Statins	Simvastatin	Indirect reduction	Approved
Farnesoid X receptor agonists	Obeticholic acid	FXR-SREBP1 axis	Approved for PBC

Lifestyle Interventions

• Calorie restriction: Reduces SREBP1 activity

• Ketogenic diet: Alternative energy substrate

• Exercise: Improves insulin sensitivity

• Omega-3 fatty acids: Counteracts dyslipidemia

Emerging Therapies

• Gene therapy: Targeted delivery

• Antisense oligonucleotides: SREBP1 knockdown

• CRISPR editing: Epigenetic modulation

Research Techniques

Experimental Methods

• ChIP-seq: Genome-wide binding analysis

• RNA-seq: Transcriptomic profiling

• Lipidomics: Comprehensive lipid analysis

• Proteomics: Protein interaction studies

• Metabolomics: Metabolic pathway analysis

Animal Models

• SREBP1 knockout: Embryonic lethal (SREBP1a), viable (SREBP1c)

• Conditional knockouts: Tissue-specific deletion

• Transgenic overexpression: Lipid accumulation models

See Also

• Lipid Metabolism Pathway

• Metabolic Dysfunction Pathway

• Alzheimer’s Disease

• Parkinson’s Disease

• Huntington’s Disease

• Cholesterol Metabolism

• SCD1 Gene

• FASN Gene

External Links

• NCBI Gene: SREBF1

• UniProt: P36956

• HGNC: SREBF1

• OMIM: 184756

Background

The study of Srebf1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.